BCH logo

Research saves children’s lives. That’s why we invest so heavily in it.

When there’s no good treatment for a patient’s condition, we bring together the right mix of physicians and scientists to find one. We partner with families and collaborators around the world, as well as medical colleagues like you.

Boston Children’s fosters innovation on all fronts – from pioneering surgical procedures, to new medical devices and digital health technologies, to simulation and 3-D printed custom anatomic models. In FY2018 alone, we disclosed 130 inventions, received 119 patents, executed 34 licensing agreements and formed seven startup companies to help bring our innovations to the patient bedside.

researchersMore than 3,000 researchers & scientific staff
research space1 million square feet of research space — and growing
Boston Children's Journal articles3,400 articles/year in peer reviewed journals— the most of any pediatric hospital
Boston Children's inventions130 invention disclosures in FY18  from research aimed at improving patient care
Boston Children's research funding$388 million in total research funding FY2018 — #1 NIH funding for pediatric research

Virtually all of Boston Children’s Hospital’s 200+ specialty programs are focused on accelerating new treatments for devastating diseases. With $388 million in total funding, we are the world’s largest pediatric research institution, and the number one children’s hospital recipient of NIH funding.

Boston Children’s has invested in a variety of research discovery platforms, including the Precision Link Biobank, a library of samples donated by nearly 10,000 patients and their families; patient-specific cell lines; genomics and other “omics” platforms; gene editing; engineered tissues and powerful bioinformatics tools.

Our mission remains the same it’s been for 150 years: to help children live their best lives. The pioneering research we do makes that possible.

Highlights: How our work is improving pediatric care




Hematology/Oncology as part of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center


Neurology and Neurosurgery


  • Co-leading the BabySeq project, a study of genomic sequencing in healthy newborns and infants in the NICU.
  • Identified key differences in neonatal immune systems and potential vaccine approaches for newborns via the Precision Vaccines Program.




Rare disease

For 150 years, families have come from around the corner and across the world, looking to Boston Children's for answers. This is the place where the most difficult challenges are faced head on, where the impossible becomes possible, and where families in search of answers find them.

Sandra L. Fenwick, CEO

Connect with Boston Children's Hospital